Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus morphine + phenobarbital for neonatal abstinence syndrome
IRCT20141028019716N6Phase 2Recruiting
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in neonatal abstinence syndrome (NAS) comparing Morphine + placebo with Morphine + phenobarbital (2 arms). Primary endpoints: Length of hospital stay, Time to symptom control and 4 more. Started Oct 2026; status: recruiting.
02
Drugs
morphinephenobarbital
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on IRCT20141028019716N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141028019716N6.